AXIM BIOTECHNOLOGIES, INC. Amortization of Leased Asset
AXIM BIOTECHNOLOGIES, INC. (AXIM) reported Amortization of Leased Asset of $7.48 thousand for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-19.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfLeasedAsset · last filed 2024-08-19
- AXIM BIOTECHNOLOGIES, INC. amortization of leased asset for the quarter ending 2024-06-30 was $7.48K, a 1.11% increase year-over-year.
- AXIM BIOTECHNOLOGIES, INC. amortization of leased asset for the quarter ending 2024-03-31 was $7.48K, a 1.11% increase year-over-year.
- AXIM BIOTECHNOLOGIES, INC. amortization of leased asset for the quarter ending 2023-06-30 was $7.40K.
- AXIM BIOTECHNOLOGIES, INC. amortization of leased asset for the quarter ending 2023-03-31 was $7.40K.
- AXIM BIOTECHNOLOGIES, INC. amortization of leased asset for fiscal 2023 was $8.88K, a 93.71% decline from fiscal 2022.
- AXIM BIOTECHNOLOGIES, INC. amortization of leased asset for fiscal 2022 was $141.13K.
- AXIM BIOTECHNOLOGIES, INC. amortization of leased asset for fiscal 2021 was $0.00.
| Period end | Amortization of Leased Asset 3 month | Amortization of Leased Asset 6 month | Amortization of Leased Asset 9 month | Amortization of Leased Asset 12 month | Amortization of Leased Asset 12 month as first filed |
|---|---|---|---|---|---|
| 2024-06-30 | $7.48K 10-Q · filed 2024-08-19 | $14.96K 10-Q · filed 2024-08-19 | |||
| 2024-03-31 | $7.48K 10-Q/A · filed 2024-05-22 | ||||
| 2023-12-31 | $8.88K 10-K · filed 2024-04-16 | ||||
| 2023-06-30 | $7.40K 10-Q · filed 2024-08-19 | $14.88K 10-Q · filed 2024-08-19 | |||
| 2023-03-31 | $7.40K 10-Q/A · filed 2024-05-22 | ||||
| 2022-12-31 | $141.13K 10-K · filed 2024-04-16 | $8.88K 10-K · filed 2023-04-17 | |||
| 2021-12-31 | -$1.33M derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | -$641.10K derived: sum of 2 quarters · filed 2023-04-17 | $0.00 derived: sum of 3 quarters · filed 2023-04-17 | $0.00 10-K · filed 2023-04-17 | |
| 2021-09-30 | $692.86K 10-Q · filed 2021-11-22 | $1.33M derived: sum of 2 quarters · filed 2021-11-22 | $1.33M 10-Q · filed 2021-11-22 | ||
| 2021-06-30 | $641.10K 10-Q · filed 2021-08-23 | $641.10K 10-Q · filed 2021-08-23 | |||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-22 | $0.00 10-Q · filed 2021-11-22 |